These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 4574006)
21. [Technology and clinical results of MCT-fat containing diets]. Horácková J; Skála I; Doberský P Z Ernahrungswiss Suppl; 1972; 13():84-9. PubMed ID: 4631167 [No Abstract] [Full Text] [Related]
22. [Blind loop syndrome]. Yoshida Y Nihon Rinsho; 1970 Mar; 28 Suppl():934-5. PubMed ID: 5430938 [No Abstract] [Full Text] [Related]
23. Medium chain triglycerides (MCT) in the treatment of protein-losing enteropathy and malabsorption syndromes. Jarnum S; Jensen H Scand J Gastroenterol; 1966; 1(4):306-13. PubMed ID: 5966089 [No Abstract] [Full Text] [Related]
24. Abetalipoproteinemia treated with parenteral and oral vitamins A and E, and with medium chain triglycerides. Azizi E; Zaidman JL; Eshchar J; Szeinberg A Acta Paediatr Scand; 1978 Nov; 67(6):796-801. PubMed ID: 716878 [TBL] [Abstract][Full Text] [Related]
25. Vitamin E and neurological function: abetalipoproteinaemia and other disorders of fat absorption. Muller DP; Lloyd JK; Wolff OH Ciba Found Symp; 1983; 101():106-21. PubMed ID: 6557902 [TBL] [Abstract][Full Text] [Related]
26. The effects of medium-chain triglycerides in the short bowel syndrome. Increased glucose and water transport. Tandon RK; Rodgers JB; Balint JA Am J Dig Dis; 1972 Mar; 17(3):233-8. PubMed ID: 5023881 [No Abstract] [Full Text] [Related]
27. [Medium chain triglycerides in the diet therapy of malabsorption syndromes]. Frizziero L Bull Sci Med (Bologna); 1969; 141(4):434-43. PubMed ID: 5375534 [No Abstract] [Full Text] [Related]
28. [Osteomalacia, intestinal malabsorption, polyadenopathy and inflammatory polyarthritis due to stagnant loop syndrome]. Rogë J; Dreyfus P; Dorfmann H; Marche C; Pironneau A; Bordier P; Silverĕano-de-Roissar ; Zechovsky N; Justin-Bensançon L Sem Hop; 1973 Jan; 49(3):163-74. PubMed ID: 4349614 [No Abstract] [Full Text] [Related]
29. Topics in clinical medicine: treatment of pancreatic insufficiency. Iber FL Johns Hopkins Med J; 1968 Mar; 122(3):172-9. PubMed ID: 4868819 [No Abstract] [Full Text] [Related]
30. [Therapeutic effects of an activated pancreatic extract in digestive insufficiency]. Fontana G; Gandolfi L; Scaletti GC; Govi D Minerva Med; 1972 May; 63(36):2059-74. PubMed ID: 5030692 [No Abstract] [Full Text] [Related]
31. Diagnosis of fat malabsorption by breath tests: just a breeze? Keller J Digestion; 2009; 80(2):95-7. PubMed ID: 19556793 [No Abstract] [Full Text] [Related]
33. Fat structure and fecal fatty acid excretion in man. Christophe A; Matthys F; Verdonk G Arch Int Physiol Biochim; 1973 Oct; 81(4):795. PubMed ID: 4128291 [No Abstract] [Full Text] [Related]
34. A physicochemical basis for treatment of enteric hyperoxaluria. Earnest DL; Williams HE; Admirand WH Trans Assoc Am Physicians; 1975; 88():224-34. PubMed ID: 1224438 [No Abstract] [Full Text] [Related]
35. [Treatment of steatorrhea by substitution of nutritional fat with middle-chain triglycerides]. Sickinger K Dtsch Med Wochenschr; 1968 Aug; 93(34):1600-3. PubMed ID: 5685949 [No Abstract] [Full Text] [Related]
36. [Medium-chain fats in dietetic treatment of some disorders of the digestive tract]. Foltyn H; Korzon M Pol Tyg Lek; 1972 Jul; 27(31):1207-10. PubMed ID: 4561156 [No Abstract] [Full Text] [Related]
37. [Value of average chain triglycerides in fat malabsorption]. Guy-Grand B; Tutin M; Dorf G; Bour H Therapeutique; 1969 Mar; 45(3):325-8. PubMed ID: 5386067 [No Abstract] [Full Text] [Related]
38. [Balanced nutrition in disturbed digestion]. Berg G; Baumbauer E Z Ernahrungswiss Suppl; 1972; 13():79-84. PubMed ID: 4631166 [No Abstract] [Full Text] [Related]
40. The development of "stagnant loop" syndrome following surgery for peptic ulcer disease. Bokey L; Hultén L; Olbe L; Schiöler R Ann Chir Gynaecol; 1978; 67(3):94-6. PubMed ID: 686642 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]